Value proposition

We develop new selective and potent drugs for intrinsically disordered targets.

Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA.

Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs.